JENNIFER MCLAUGHLIN: Open Payments
NPI 1184237174 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 45 payments from 19 companies in 2025. Trend: 2023 $1,024 · 2024 $985 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $202 |
| AstraZeneca Pharmaceuticals LP | 9 | $164 |
| ABBVIE INC. | 7 | $141 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Exact Sciences Corporation | 2 | $47 |
| TMS NeuroHealth Centers Inc. | 1 | $33 |
| Alvogen Inc | 1 | $24 |
Products named: EVENITY, AIRSUPRA, VRAYLAR, FARXIGA, Wegovy, UBRELVY, CAPLYTA, Cologuard Collection Kit.
Industry payments across AK — which companies pay providers there.
